Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -11.54-12.5144.9880.9850.75

What is the latest Core EBITDA Growth ratio of INDOCO REMEDIES ?

The latest Core EBITDA Growth ratio of INDOCO REMEDIES is -11.54 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-11.54
Mar2023-12.51
Mar202244.98
Mar202180.98
Mar202050.75

How is Core EBITDA Growth of INDOCO REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2024 -11.54
Negative
Mar2023 -12.51
Negative
Mar2022 44.98
-44.46
Mar2021 80.98
59.57
Mar2020 50.75 -

Other Financial Ratios of INDOCO REMEDIES


Compare Core EBITDA Growth ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹3,085.5 Cr 3.4% -1.2% -15.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,557.0 Cr 2.3% -0.8% 32.7% Stock Analytics
DIVIS LABORATORIES ₹156,994.0 Cr 3.2% 1.1% 51.5% Stock Analytics
CIPLA ₹116,494.0 Cr 0.3% -2% 10% Stock Analytics
DR REDDYS LABORATORIES ₹109,297.0 Cr -1.8% 2.7% 12.7% Stock Analytics
ZYDUS LIFESCIENCES ₹100,035.0 Cr 2% 1.5% 38% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

3.4%

-1.2%

-15.4%

SENSEX

-1%

-5%

5.6%


You may also like the below Video Courses